Acelyrin, Inc. (SLRN) Tops Q3 EPS by 70c
Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.49), $0.70 better than the analyst estimate of ($1.19).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.
Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.49), $0.70 better than the analyst estimate of ($1.19).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.